PFE
Pfizer Inc. · Healthcare · Drug Manufacturers - General
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +3 | 3.07B | $73.90B | +7 | −3 |
| Q1 2026 | 174 | -2 | 3.01B | $84.42B | +3 | −6 |
| Q4 2025 | 175 | 0 | 3.18B | $79.18B | +2 | −1 |
| Q3 2025 | 25 | -1 | 1.84B | $46.80B | +1 | −3 |
| Q2 2025 | 24 | -1 | 1.79B | $43.32B | — | −1 |
| Q1 2025 | 22 | +1 | 777.51M | $19.69B | +2 | −1 |
| Q4 2024 | 21 | +2 | 779.18M | $20.66B | +2 | — |
| Q3 2024 | 18 | -2 | 507.62M | $14.68B | — | −2 |
| Q2 2024 | 20 | — | 545.09M | $15.24B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 166.32M | — | $4.65B | 0.8% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 115.81M | — | $3.23B | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 115.81M | — | $3.23B | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Capital World Investors ✦ | 88.14M | — | $2.47B | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (passief) | 83.96M | — | $2.35B | 0.4% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 20.40M | — | $570.67M | 0.6% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 20.40M | — | $570.67M | 0.6% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 19.92M | — | $557.41M | 0.5% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 17.09M | — | $478.23M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 17.09M | — | $478.23M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 8.71M | — | $243.66M | 0.6% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 8.42M | — | $235.72M | 0.4% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 8.42M | — | $235.72M | 0.4% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 5.38M | — | $150.48M | 0.2% | n/c | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 5.38M | — | $150.48M | 0.2% | n/c | 1 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 4.70M | — | $131.51M | 0.2% | n/c | 1 | SEC ↗ |
| 25 | Fisher Asset Management ✦ | 1.90M | — | $53.19M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 1.78M | — | $49.92M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | Point72 Asset Management ✦ | 712.20K | — | $19.93M | 0.1% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 612.43K | — | $17.07M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 612.43K | — | $17.07M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 612.43K | — | $17.07M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | GAMCO Investors ✦ | 580.66K | — | $16.25M | 0.2% | n/c | 1 | SEC ↗ |
| 32 | Fairfax Financial ✦ | 460.90K | — | $12.90M | 1.1% | n/c | 1 | SEC ↗ |
| 33 | Dodge & Cox ✦ | 115.94K | — | $3.24M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Bridgewater Associates ✦ | 35.43K | — | $991,247 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Gotham Asset Management ✦ | 25.48K | — | $712,818 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 225.90K aandelen, $6,343 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · Chairman & CEO · 38.00K aand @ 26.34 · $1.00M
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie